The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
200 jobs Number of planned job creations
Announcement Date
19 October 2015
Employment effect (start)
19 October 2015
Foreseen end date
19 October 2017
Description
Pharmaceutical firm Regeneron is creating 200 new jobs over the next two years, as part of a €310 million investment. The company's plant is in Raheen, Co. Limerick, where 300 are already employed. The jobs are in roles such as commercial manufacturing, process sciences, quality assurance/control and various support functions for scientists, chemists and technicians. The plant in Limerick is the American company's only manufacturing plant outside of the USA.
Sources
19 October 2015: RTE
19 October 2015: Silicon Republic.com
Citation
Eurofound (2015), Regeneron, Business expansion in Ireland, factsheet number 85122, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/85122.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
